Overview

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

Status:
Completed
Trial end date:
2006-04-10
Target enrollment:
Participant gender:
Summary
The purpose of this study if to investigate the effect of lonafarnib (SCH66336) in combination with Gleevec in the treatment of CML.
Phase:
Phase 1
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Imatinib Mesylate
Lonafarnib